Finance

Lists
Why is 3696 up 3.88%?
Dive Deeper
3696:HKG
Insilico Medicine Cayman TopCo
HK$ 39.10
+3.88%
(+1.46) 1D
10-р сарын 16, 16:08:14 (GMT+8)  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3696...
Open
HK$ 39.16
High
HK$ 40.28
Low
HK$ 38.12
Mkt. cap
22.88 тэрбум
Avg. vol.
15.66 сая
Volume
15.71 сая
52-wk high
HK$ 80.90
52-wk low
HK$ 29.98
EPS
-HK$ 4.20
Shares outstanding
557.42 сая
No. of employees
333
Open
HK$ 39.16
High
HK$ 40.28
Low
HK$ 38.12
Mkt. cap
22.88 тэрбум
Avg. vol.
15.66 сая
Volume
15.71 сая
52-wk high
HK$ 80.90
52-wk low
HK$ 29.98
EPS
-HK$ 4.20
Shares outstanding
557.42 сая
No. of employees
333
News stories
From web sources and news partners
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees333
Founded2014
Headquarters-
SectorHealth care
Last report
2026 оны 8-р сарын 26
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
53.15 сая / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
14.39 сая
14.39 сая
53.15 сая
53.15 сая
Cost of goods sold
2.98 сая
2.98 сая
5.17 сая
5.17 сая
Cost of revenue
2.98 сая
2.98 сая
5.17 сая
5.17 сая
Research and development expenses
22.90 сая
22.90 сая
24.66 сая
24.66 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.05 сая
7.05 сая
9.47 сая
9.47 сая
Operating expense
30.23 сая
30.23 сая
33.85 сая
33.85 сая
Total operating expenses
33.20 сая
33.20 сая
39.02 сая
39.02 сая
Operating income
-18.81 сая
-18.81 сая
14.14 сая
14.14 сая
Other non operating income
-149.82 сая
-149.82 сая
1.50 мян
1.50 мян
EBT including unusual items
-166.54 сая
-166.54 сая
17.91 сая
17.91 сая
EBT excluding unusual items
-167.61 сая
-167.61 сая
16.57 сая
16.57 сая
Income tax expense
9.50 мян
9.50 мян
139.50 мян
139.50 мян
Effective tax rate
-0.01%
-0.01%
0.78%
0.78%
Other operating expenses
-
-
-
-
Net income
-166.55 сая
-166.55 сая
17.77 сая
17.77 сая
Net profit margin
-1,157.28%
-1,157.28%
33.43%
33.43%
Earnings per share
-
-
-
-
Interest and investment income
1.29 сая
1.29 сая
3.89 сая
3.89 сая
Interest expense
-56.00 мян
-56.00 мян
-83.00 мян
-83.00 мян
Net interest expenses
1.24 сая
1.24 сая
3.81 сая
3.81 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.08 сая
-18.08 сая
14.89 сая
14.89 сая
Gain or loss from assets sale
63.50 мян
63.50 мян
-
-
AI content may include mistakes. Learn more
Google аппс